Despite Verdict, Stratagene Still Free to Sell Competent-Cell Products -- for the Moment | GenomeWeb

NEW YORK, Oct. 13 (GenomeWeb News) - Stratagene is free to sell its competent-cell products until a District Court addresses the suit between it and Invitrogen again, according to an Invitrogen official.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.